e-learning
resources
Milan 2017
Sunday, 10.09.2017
Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Obstructive Sleep Apnoea is a Pulmonary Embolism severity risk factor.
N. Toledo Pons (PALMA DE MALLORCA, Spain)
Source:
International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea
Session:
Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea
Session type:
Poster Discussion
Number:
326
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Toledo Pons (PALMA DE MALLORCA, Spain). Obstructive Sleep Apnoea is a Pulmonary Embolism severity risk factor.. 326
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Imaging of complicated pneumonia: what is new?
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Related content which might interest you:
Prevalence of Obstructive Sleep Apnea in Idiopathic Pulmonary fibrosis
Source: International Congress 2018 – Obesity: comorbidities
Year: 2018
The role of positive airway pressure treatment for Obstructive Sleep Apnea in Pulmonary Embolism
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020
Obstructive Sleep Apnea severity and lung function
Source: International Congress 2018 – Diagnostics including questionnaires
Year: 2018
Cognitive impairment in patients with Idiopathic Pulmonary Fibrosis - Obstructive Sleep Apnea Overlap
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
Chronic Obstructive Pulmonary Disease Exacerbations
Source: Eur Respir Rev 2009; 18: 305
Year: 2009
Obstructive sleep apnoea and risk of recurrent venous thromboembolism
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016
The Effects Of Bronchiectasis Severity On Outcomes Of Chronic Obstructive Pulmonary Disease Exacerbation
Source: International Congress 2017 – Imaging markers for COPD and asthma
Year: 2017
Is Obstructive Sleep Apnea a risk factor for Gestational Diabetes?
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020
Association of Metabolic Syndrome with the severity of Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020
Influence of Obstructive Sleep Apnea on systemic inflammation in pregnancy
Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders
Year: 2020
Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD)
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020
The ALONNISOS STUDY: Cross-sectional study of the prevalence of Obstructive Sleep Apnea Syndrome (OSAS) and Chronic Obstructive Pulmonary Disease (COPD) in the general population of Alonissos.
Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases
Year: 2020
Determinants of Airflow Limitation in Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020
Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir Rev 2009; 18: 133
Year: 2009
“Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Diagnosis of Moderate-to-severe Obstructive Sleep Apnea Syndrome based on the Sleep clinical record.
Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children
Year: 2019
Investigation of Obstructive Sleep Apnea in Adult Non-Cystic Fibrosis Bronchiectasis Patients
Source: International Congress 2019 – Clinical problems
Year: 2019
Minimal clinically important difference in Barthel dyspnoea after pulmonary rehabilitation in patients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Novelties in pulmonary rehabilitation and chronic respiratory care
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept